TrianglePUBLICATIONS · 37695474
Azacitidine (Vidaza(®)) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015).
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Paediatr Drugs
- Publication date
- 2023 Nov
- First author
- Rubio-San-Simón A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Rubio-San-Simón A
- type
- Author
- name
- van Eijkelenburg NKA
- type
- Author
- name
- Hoogendijk R
- type
- Author
- name
- Hasle H
- type
- Author
- name
- Niemeyer CM
- type
- Author
- name
- Dworzak MN
- type
- Author
- name
- Zecca M
- type
- Author
- name
- Lopez-Yurda M
- type
- Author
- name
- Janssen JM
- type
- Author
- name
- Huitema ADR
- type
- Author
- name
- van den Heuvel-Eibrink MM
- type
- Author
- name
- Laille EJ
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Rubio-San-Simón A
- type
- Author
- name
- van Eijkelenburg NKA
- type
- Author
- name
- Hoogendijk R
- type
- Author
- name
- Hasle H
- type
- Author
- name
- Niemeyer CM
- type
- Author
- name
- Dworzak MN
- type
- Author
- name
- Zecca M
- type
- Author
- name
- Lopez-Yurda M
- type
- Author
- name
- Janssen JM
- type
- Author
- name
- Huitema ADR
- type
- Author
- name
- van den Heuvel-Eibrink MM
- type
- Author
- name
- Laille EJ
- type
- Author
- bibliography ids
- nci-bib-c8a89dd2aa3f5bd4c9840acd
- book metadata
- content sha256
- 72fc8f9707bfaaa3cdb2b41efc1011e39ab73ee6f020bb0a3099e45aa93ab05a
- document type
- citation
- dois
- 10.1007/s40272-023-00588-5
- electronic publication date
- display
- 2023 Sep 11
- precision
- day
- year
- 2023
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:37695474
- immutable id
- pubmed:37695474@72fc8f9707bfaaa3cdb2b41efc1011e39ab73ee6f020bb0a3099e45aa93ab05a
- journal
- abbreviation
- Paediatr Drugs
- issn electronic
- 1179-2019
- issn print
- 1174-5878
- issue
- 6
- name
- Paediatric drugs
- nlm unique id
- 100883685
- pages
- 719-728
- volume
- 25
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 37695474
- provenance
- batch id
- 5329a5d0877ee70ecd11
- provider
- NCBI PubMed ESummary
- record sha256
- 064702106d7d0658bddf03f7e12c64f62ae05163a542f19b03aeb368c1955852
- response sha256
- bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
- retrieved at
- 2026-09-09T23:48:15.763286+00:00
- publication date
- display
- 2023 Nov
- precision
- month
- year
- 2023
- publication types
- Multicenter Study
- Clinical Trial, Phase II
- Clinical Trial, Phase I
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Azacitidine (Vidaza(®)) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015).
Preserved source evidence · Not medical advice